Figure 3E shows that recombinant CCL2 proteins attenuated the inhibitory effect of rVP1 on cell growth, indicating that the reduced level of CCL2 in rVP1-treated mice may also be involved in the mechanism of delayed tumor progression. Here, CLDN3 is linked to neoplasm.